Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enovix Corporation (ENVX) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Enovix CorporationTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Enovix Corporation vs Vir Biotechnology Inc. Common Stock — how do they compare? Enovix Corporation trades at $2.41 (market cap $550.82M), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Vir Biotechnology Inc. Common Stock is far larger — about 3.3× Enovix Corporation's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Enovix Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enovix Corporation for 11 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

ENVXVIR
Market Cap
$550.82M$1.80B
Volume
5,977,8721,782,836
Sector
IndustrialsHealth
52-Week High
$13.19$11.78
52-Week Low
$2.44$5.12
Typical Hold Time
11 Days0 Days
Enterprise Value
$612.51M$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enovix Corporation

ENVX trades at $2.51, down 3.09% on the day, reflecting bearish technical signals and negative profitability. The company reported a net loss of -$156.74M in 2025, with revenue of $31.82M, while recent quarterly EPS has consistently beaten expectations. Key developments include a CEO transition in August 2026 and expansion of drone battery capacity in South Korea.

Despite deep losses and cash burn, analyst consensus remains bullish with a $9.60 price target, citing potential in defense and smartphone battery markets. Risks include high cash burn, leadership changes, and competitive pressures. The stock's outlook hinges on successful commercialization and margin improvement.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ENVX
7% Buy93% Sell
Avg holding period · 11 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Enovix Corporation

Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.

Read more on ENVX →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →